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The agro-industrial exploitation of eucalyptus for pulp production generates large amounts of 
biomass residues, particularly bark. Eucalyptus spp. is the most important fiber source for 
pulp and paper production in southwestern Europe [1]. 
 Fig. 1: Antiproliferative effect of Eucalyptus ritens Crude, F2 extracts and triterpenic acids 
on human breast cancer cells. Dose-response curves of E. nitens Crude (A) and F2 (B) 
extracts and UA (C), OA (D), BA (E) and BoA (F) treatment in MDA-MB-231 cells. 
Eucalyptus spp. barks are an abundant source of several triterpenoids, mostly triterpenic acids 
(TAs), namely betulinic (BA), oleanolic (OA), ursolic (UA) and betulonic (BOA) acids [2]. 
These pentacyclic triterpenes have a broad spectrum of biological activities, being some of 
them considered promising anticancer drugs [3]. Therefore, the present work aims to 
characterize the anti-tumoral activity of pure TAs (UA, OA, BA and BOA) as well as total 
and fractionated (enriched on different TAs) Eucalyptus nitens outer bark derived extracts, in 
a breast cancer in vitro cell model. The crude and fractionated E. nitens outer bark extracts 
were previously chemically characterized [2]. Crude and Fractionated (F2) extracts inhibited 
the proliferation of MDA-MB-231 cells in a dose- and time-dependent manner. Treatment of 
MDA-MB-231 cells with crude and F2 extracts resulted in a significant reduction in cell 
migration, as compared to vehicle control. Cell cycle analysis was also assessed by flow 
cytometry. Since the phosphatidylinositol 3-kinase(PI3K)/Akt is the signalling pathway 
frequently implicated in oncogenic transformation in breast cancer, the phosphor-Akt protein 
levels were also determined. Taken together, our study suggests potential therapeutic effect 
of Eucalyptus spp. bark extracts against an aggressive breast cancer cell model. 
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